Collectively, these data demonstrate that RKIP-regulated NPC cell radioresponse is mediated through ERK and AKT signaling, and RKIP reduction promotes NPC cell radioresistance by increasing ERK and AKT activity. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.